Hyperphosphataemia after Desoxycorticosterone Pivalate in dogs

The FDA has received 71 reports of hyperphosphataemia in dogs after Desoxycorticosterone Pivalate. That is 2.1% of all reports for this medicine, compared with 0.6% across reports for all dog medicines, so it is reported unusually often with this medicine.

71Reports
62%Marked serious
5.6%Recovered
24%Died or euthanised
31 daysTypical onset
SponsoredWorried about your pet? Ask a veterinarian online, 24/7

How soon it started

Same day
3 11%
1–2 days
1 3.6%
3–7 days
1 3.6%
1–4 weeks
7 25%
Over a month
16 57%

How the animals did

Recovered
3 4.2%
Recovered with lasting effects
1 1.4%
Still unwell when reported
17 24%
Died
11 15%
Euthanised
6 8.5%
Not known
33 46%

Problems reported at the same time

Age of the animals

Under 1 year
1
1–3 years
9
4–7 years
17
8–11 years
27
12+ years
13

About this medicine

Type: medicine.

Questions owners ask

Can Desoxycorticosterone Pivalate cause hyperphosphataemia in dogs?
71 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?
In half of the reports with dates, it started within 31 days of the first dose.
What should I do?
Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Hyperphosphataemia with similar medicines

All reported side effects of Desoxycorticosterone Pivalate in dogs · Medicines most reported with hyperphosphataemia